Keyphrases
Reverse Transcriptase Inhibitors
66%
Central Nervous System
66%
Nanodelivery
66%
Humanized
66%
Nanogel
23%
Neurotoxicity
20%
Blood-brain Barrier
16%
Mitochondrial Toxicity
10%
Didanosine
10%
Human Immunodeficiency Virus Type 1 (HIV-1)
10%
HIV-1 Infection
10%
Highly Active Antiretroviral Therapy (HAART)
10%
Specific Intent
10%
Cellular Systems
6%
Further Development
6%
Systemic Delivery
6%
Encephalitis
6%
Macrophages
6%
Murine Model
6%
Antiviral Efficacy
6%
Nucleoside Analogues
6%
5-bisphosphate
6%
Chemotherapy
6%
Activation Loss
5%
ApoE Peptide
5%
New Drug Modality
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
RNA Directed DNA Polymerase Inhibitor
100%
Nanogel
40%
Neurotoxicity
25%
Antivirus Agent
25%
Blood-Brain Barrier
25%
Didanosine
15%
Mitochondrial Toxicity
15%
Human Immunodeficiency Virus 1 Infection
15%
Chemotherapy
10%
Nucleoside Analog
10%
Encephalitis
10%
Inflammation
5%
Pharmacotherapy
5%
Murine
5%
Mouse Model
5%
Drug Formulation
5%
Side Effect
5%
Zidovudine
5%